Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianxun Ding

Showing results (1-10 of 271) with videos related to

Pageof 28
Sort By:
BME Frontiers|October 18, 2023
Nanoantidotes: A Detoxification System More Applicable to Clinical PracticeJiazhen Yang, Jianxun Ding
Current Pharmaceutical Design|March 8, 2018
Editorial: Advanced Antimicrobial Materials and InterfacesJunchao Wei, Jianxun Ding
Asian Journal of Pharmaceutical Sciences|March 9, 2022
Calcium ion nanomodulators for mitochondria-targeted multimodal cancer therapyPan Zheng, Jianxun Ding
Biomacromolecules|February 17, 2026
Bioactive Poly(amino acid) Nanomaterials Potentiate Cancer ImmunotherapyGuanqing Yang, Jianxun Ding
Biosafety and Health|March 22, 2022
Advanced biosafety materials for prevention and theranostics of biosafety issuesJianxun Ding, Haihua Xiao, Xuesi Chen
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|August 5, 2024
Bioactive poly(amino acid)s for multi-modal cancer therapyGuanqing Yang, Jianxun Ding, Xuesi Chen
Advanced Healthcare Materials|May 21, 2024
Biomaterials-Boosted Immunotherapy for OsteosarcomaChao Sun, Shuqiang Li, Jianxun Ding
Nanomedicine (London, England)|January 13, 2025
Biomaterials-mediated biomineralization for tumor blockade therapyChao Sun, Shuqiang Li, Jianxun Ding
Journal of Materials Chemistry. B|June 6, 2022
Rational construction of polycystine-based nanoparticles for biomedical applicationsJinjin Chen, Jiazhen Yang, Jianxun Ding
Signal Transduction and Targeted Therapy|January 13, 2021
Identification of MSA-2: An oral antitumor non-nucleotide STING agonistJianhua Liu, Xu Huang, Jianxun Ding
Pageof 28

Showing results (1-10 of 271) with videos related to

Sort By:
Pageof 28
BME Frontiers|October 18, 2023
Nanoantidotes: A Detoxification System More Applicable to Clinical PracticeJiazhen Yang, Jianxun Ding
Current Pharmaceutical Design|March 8, 2018
Editorial: Advanced Antimicrobial Materials and InterfacesJunchao Wei, Jianxun Ding
Asian Journal of Pharmaceutical Sciences|March 9, 2022
Calcium ion nanomodulators for mitochondria-targeted multimodal cancer therapyPan Zheng, Jianxun Ding
Biomacromolecules|February 17, 2026
Bioactive Poly(amino acid) Nanomaterials Potentiate Cancer ImmunotherapyGuanqing Yang, Jianxun Ding
Biosafety and Health|March 22, 2022
Advanced biosafety materials for prevention and theranostics of biosafety issuesJianxun Ding, Haihua Xiao, Xuesi Chen
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|August 5, 2024
Bioactive poly(amino acid)s for multi-modal cancer therapyGuanqing Yang, Jianxun Ding, Xuesi Chen
Advanced Healthcare Materials|May 21, 2024
Biomaterials-Boosted Immunotherapy for OsteosarcomaChao Sun, Shuqiang Li, Jianxun Ding
Nanomedicine (London, England)|January 13, 2025
Biomaterials-mediated biomineralization for tumor blockade therapyChao Sun, Shuqiang Li, Jianxun Ding
Journal of Materials Chemistry. B|June 6, 2022
Rational construction of polycystine-based nanoparticles for biomedical applicationsJinjin Chen, Jiazhen Yang, Jianxun Ding
Signal Transduction and Targeted Therapy|January 13, 2021
Identification of MSA-2: An oral antitumor non-nucleotide STING agonistJianhua Liu, Xu Huang, Jianxun Ding
Pageof 28